Study Stopped
Due to the pandemic's impacts on being able to conduct the intervention for this study, unable to begin recruitment.
NYCHA Mindfulness-based Smoking Cessation Intervention
Feasibility and Accessibility of a Mindfulness-based Smoking Cessation Intervention for NYCHA Residents
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The study will assess feasibility, accessibility and impact of a mindfulness-based smoking cessation group intervention for New York City Housing Authority (NYCHA) residents. Residents who smoke to receive an 8-week intervention. Participants will also be offered 4 weeks of nicotine replacement therapy (NRT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2020
CompletedFirst Posted
Study publicly available on registry
April 6, 2020
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 2, 2022
February 1, 2022
6 months
March 26, 2020
February 25, 2022
Conditions
Outcome Measures
Primary Outcomes (4)
Number of participants who perceive the Mindfulness based addiction treatment as useful at time of Enrollment
Participants will report their perceived usefulness and effectiveness of the intervention using self reported surveys at enrollment (baseline).
Baseline
Number of participants who perceive the Mindfulness based addiction treatment as useful after last MBAT session.
Number of participants will report their perceived usefulness and effectiveness of the intervention using self reported surveys after their last MBAT session (2 months after enrollment).
2 months
Number of participants who perceive the Mindfulness based addiction treatment as useful post treatment
Participants will report their perceived usefulness and effectiveness of the intervention using self reported surveys one month after completing treatment (3 months post-enrollment).
3 months
Number of participants who perceive the Mindfulness based addiction treatment as effective
Participants who self-report 7-day abstinence in the final follow up survey (3 months) will provide a biochemically validated saliva sample
3 months
Secondary Outcomes (2)
Number of participants who adhered to the Mindfulness based addiction treatment
3 months
Number of participants who self reported abstinence
2 months
Study Arms (1)
Smoke Cessation Group
EXPERIMENTALMindfulness-based smoking cessation sessions will follow the mindfulness based addiction treatment (MBAT) intervention for smoking cessation. Sessions are in group format for two hours, weekly. Two groups of sessions with about 10 participants per group will be organized.
Interventions
The intervention is comprised of 8 weekly group MBAT sessions. Two weekly groups of about 10 participants each will be conducted. All participants will also have the option to receive nicotine patches, gum, or lozenges for four weeks as part of their time in the study. Participants will complete surveys at enrollment (baseline), immediately after their last MBAT session (around 2 months after enrollment) and one month after completing treatment (3 months post-enrollment). Surveys will assess primary and secondary outcomes and satisfaction with the intervention.
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Current smoker (\>= 5 cigarettes per day). Dual tobacco users are eligible as long as their primary tobacco product is cigarettes.
- Ready to quit smoking cigarettes within 30 days
- Able to attend the 8 weekly MBAT sessions at the scheduled days/times
- NYCHA resident
- English language
- Able to provide informed consent
You may not qualify if:
- Pregnant or breastfeeding
- Patient Health Questionnaire-2 (PHQ-2) score indicating current risk for depression
- Self-reported diagnosis of schizophrenia, bipolar disorder, schizotypal disorder or other psychotic disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Rogers
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2020
First Posted
April 6, 2020
Study Start
June 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
March 2, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data. Upon reasonable request. Requests should be directed to Erin.rogers@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.
Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)